HIV-1 remains a global health challenge, with over 35 million people infected. The high rates of turnover and evolutionary adaptability exhibited by HIV-1 pose a particular challenge to the use of antiretrovirals, as well as the development of a vaccine. Our focus is to understand the dynamics of two of the most commonly tracked clinical markers of an HIV-1 infection: CD4+ T cells/mm3 (CD4 count) and HIV-1 RNA/ml (viral load).
Join a thriving innovation ecosystem. Subscribe now